Stay updated on Abaloparatide-Solid Microstructured Transdermal System Clinical Trial

Sign up to get notified when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; the study details content remains unchanged.
    Difference
    0.0%
    Check dated 2026-03-19T04:47:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:32.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Layout and visual appearance appear updated, while core study data such as arms, outcomes, eligibility, enrollment, and locations seem unchanged.
    Difference
    0.0%
    Check dated 2026-02-25T19:03:54.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a site revision tag 'Revision: v3.4.2' and removed an outdated government-operating-status notice along with the earlier tag 'Revision: v3.4.1'. No trial data, eligibility criteria, or results were altered.
    Difference
    0.2%
    Check dated 2026-02-11T11:51:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a system notice about government funding lapse and NIH operations, and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T06:29:38.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option and normalize capitalization for QC-related labels (Last Update Submitted that Met QC Criteria) and No FEAR Act Data, plus a new Revision: v3.4.0 note. The previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) are removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:34:46.000Z thumbnail image

Stay in the know with updates to Abaloparatide-Solid Microstructured Transdermal System Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.